Overview

Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy

Status:
Completed
Trial end date:
2003-01-29
Target enrollment:
Participant gender:
Summary
This study includes patients 16 years of age or older with a confident diagnosis of epilepsy who are currently treated with an antiepileptic drug (AED) monotherapy but require a change in therapy due to inadequate seizure control and/or unacceptable side effects.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Lamotrigine